Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma, Kaposi × Mitoxantrone × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia 11 Prostatic Neoplasms 10 Lymphoma 9 Leukemia, Erythroblastic, Acute 8 Leukemia, Myelomonocytic, Acute 7 Leukemia, Monocytic, Acute 7 Congenital Abnormalities 7 Lymphoma, Follicular 6 Leukemia, Megakaryoblastic, Acute 6 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 5 Leukemia, Biphenotypic, Acute 5 Recurrence 3 Sarcoma, Myeloid 2 Neoplasms 2 Myeloproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Waldenstrom Macroglobulinemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Myeloid Malignancies 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, T-Cell 1

Interventions

Valganciclovir 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 pomalidomide 1 pembrolizumab 1 liposomal doxorubicin 1 emvododstat 1 efineptakin alfa 1 Zidovudine 1 Sunitinib 1 Polymerase Chain Reaction 1 Nivolumab 1 Nelfinavir 1 Maraviroc 1 Lenalidomide 1 Ipilimumab 1 Immunohistochemistry 1 Imatinib Mesylate 1 HhAntag691 1 Gene Expression Profiling 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 CTLA-4 Antigen 1 Antiretroviral Therapy, Highly Active 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡